PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband
Quattro® X Suture Anchor With BroadBand™ Tape Post Market Clinical Follow-up Study (Incl. Instruments)
1 other identifier
observational
106
1 country
2
Brief Summary
The study is a multicenter, retrospective and prospective, non-randomized, noncontrolled, and consecutive series post-market study. The purpose of this study is collect data confirming safety, performance and clinical benefits of the Quattro® X Suture Anchor with BroadBand™ Tape and Instruments when used in rotator cuff repair. The primary endpoint of this study is the assessment of performance by analyzing soft tissue to bone healing in the shoulder (rotator cuff). Healing will be assessed by the investigator using PROMs and clinical outcomes of the patient. The clinical benefit will be assessed by functional outcomes measured using standard and well-established scoring systems (e.g. Constant \& Murley and EQ-5D-5L) at 1 year post-operative. The safety will be assessed by monitoring the incidence and frequency of device- and/or procedure-related adverse events.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2022
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 17, 2022
CompletedFirst Submitted
Initial submission to the registry
December 19, 2022
CompletedFirst Posted
Study publicly available on registry
January 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 9, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2024
CompletedResults Posted
Study results publicly available
September 10, 2025
CompletedSeptember 10, 2025
December 1, 2024
2.1 years
December 19, 2022
August 12, 2025
September 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of Performance by Analyzing Soft Tissue to Bone Healing in the Shoulder (Rotator Cuff)
The investigator will clinically evaluate at 1 year follow-up visit if soft tissue to bone healing has occurred by the absence of device-related revisions and re-tears that were not previously reported. The following question will be asked to the investigator: "Did soft tissue to bone healing occur"? If "yes" is answered, then the soft tissue to bone healing is successful, if "no" is answered, then the soft tissue to bone healing is considered unsuccessful.
From operation to study completion, 0-1 year
Secondary Outcomes (7)
Constant and Murley Score
From operation to study completion, 0-1 year
EQ-5D-5L Score
From operation to study completion, 0-1 year
Assessment of Safety
From operation to study completion, 0-1 year
Subjective Shoulder Value
From operation to study completion, 0-1 year
Pain / Anti-Inflammatory Medication
1 year after surgery
- +2 more secondary outcomes
Study Arms (1)
Patients who received the Quattro X BroadBand
No specific interventions will be administered.
Eligibility Criteria
Subjects treated with the Quattro® X Suture Anchor with BroadBand™ Tape for rotator cuff repair, according to the IFU and who meet all of the inclusion and none of exclusion criteria.
You may qualify if:
- Subject treated with the Quattro® X Suture Anchor with BroadBand™ Tape for rotator cuff repair;
- Older than 18 years and skeletally mature;
- Willing and able to comply with the study procedures;
- Subject is capable of understanding the doctor's explanations, following his instructions and is able to participate in the follow-up program;
- Subject is able to read and understand the ICF and has voluntarily provided written informed consent.
You may not qualify if:
- Presence of infection;
- Insufficient or immature bone;
- Insufficient blood supply or previous infections which may hinder the healing process;
- Foreign body sensitivity;
- Subject is vulnerable (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, anticipated to be non-compliant);
- The subject is unwilling or unable to give consent or to comply with the follow-up program;
- Subject meets any contraindications of the appropriate Instruction for Use.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zimmer Biometlead
Study Sites (2)
Ortheo
Saint-Etienne, 42100, France
Centre Clinical
Soyaux, 16800, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Julie Nicoux
- Organization
- Zimmer Biomet
Study Officials
- STUDY DIRECTOR
Hassan Achakri
Zimmer Biomet
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2022
First Posted
January 19, 2023
Study Start
June 17, 2022
Primary Completion
August 9, 2024
Study Completion
November 15, 2024
Last Updated
September 10, 2025
Results First Posted
September 10, 2025
Record last verified: 2024-12